Knowledge Center

Patent / Sep 01, 2013

Detoxification of Active Pharmaceutical Ingredients For Nano-Filtration

Authors:
  • Joao Bandarra
  • Gyorgy Szekely
Source:
PT 105601

The invention describes the use of nanofiltration of org. solvents as a general platform for removing genotoxic impurities, also known as genotoxins, used as a reagent or formed during the synthesis of active pharmaceutical ingredients or their intermediates.  The invention thus focuses, in particular, on the removal of the most common classes of genotoxic impurities using membranes.

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Drug Substance Integrated Offering

Hovione’s industry-leading particle science and tableting capabilities accelerate your path to commercialization by seamlessly bridging Drug Substance to Drug Product at a single site through a single interface-one project, one team approach.

Page
Read more